Anthem to purchase non-hospice palliative care provider Aspire Health
Date: 2018-05-25   Author: Dhananjay Punekar  Category: #industry

Anthem Inc., a U.S. based health insurance firm, has declared that it is going to acquire Aspire Health, an outpatient palliative care provider. The deal marks a new era for the insurance firms that are trying to explore the non-hospice provider space with an aim to reduce costs of patient care.

As per some of the key officials of Anthem, the acquisition will help the firm provide integrated care to its end-users while simultaneously bringing about an improvement in healthcare outcomes at lower costs. Reportedly, the deal is likely to be finalized in the third quarter of this year subject to the approvals from regulatory bodies.

With this acquisition, Aspire Health will also be added to Anthem’s other palliative-care provider assets such as AIM Specialty Health and CareMore Health. For the record, Aspire offers its services to customers in twenty-five states of the U.S. and has entered into contracts with over twenty healthcare plans. Post the identification of patients with serious illnesses, Aspire allocates a team of healthcare professionals, including doctors, chaplains, nurses, and social workers, in addition to offering facilities of home care services.

Brad Smith, the CEO of Aspire Health, has stated that the advanced illness projects are capable of providing high patient & family satisfaction, thereby not only raising customer satisfaction index, but also reducing the number of cases of hospitalization and costs. A key official of Aspire has further emphasized that the acquisition will help the company improve its business operations, favorably impacting the lives of the patients as well as their families. The move is likely to make the home-based illness treatment easily accessible to the patients who require it the most.

Experts predict that the deal to be neutral in terms of earnings this year and accretive to earnings next year.

Incidentally, just last year, Anthem was also involved in the purchase of HealthSun, a Medicare Managed Care firm.



About Author


Dhananjay Punekar

Dhananjay Punekar

Dhananjay currently works as a content writer at AlgosOnline. A post graduate in mathematics as well as business administration, he worked as a process executive in Infosys BPO Limited before switching his professional genre. Following his childhood passion, he opted fo...

Read More

More from Dhananjay


Post Recommendents

Contraceptives Market Growth, Business Analysis & Industry Report 2024
Author: Rahul Sankrityayan

Contraceptives Market was valued at USD 21.1 billion in 2016 and is projected to witness 6.8% CAGR growth from 2017 to 2024.

Contraceptive market will witness ...


Cancer Biological Therapy Market Analysis, Trends & Growth Forecast 2024
Author: Rahul Sankrityayan

Cancer Biological Therapy Market size is anticipated to experience significant growth of 6% from 2016 to 2023.

Rising prevalence of cancer patients around the globa...


Fuel Cell Electric Vehicle Market set for massive growth from 2017 to 2024
Author: Ronak Bora

Global fuel cell electric vehicle Market is predicted to cross 300 thousand units over the projected time span. Increasing R&...